Halozyme Therapeutics
HALO
$38.46
Share price
-1.69%
Change (1 day)
14.57%
Change (1 year)
Categories
Halozyme Therapeutics (HALO) - Net assets
Net assets on the balance sheet as of December 2023 : $83.8 M
According to Halozyme Therapeutics's latest financial reports the company has $83.8 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Halozyme Therapeutics - Net assets on balance sheet (from 2002 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $83.8 M | -50.64% |
| 2022-12-31 | $0.16 B | -13.79% |
| 2021-12-31 | $0.19 B | 30.39% |
| 2020-12-31 | $0.15 B | 64.6% |
| 2019-12-31 | $91.76 M | -63.13% |
| 2018-12-31 | $0.24 B | 19.45% |
| 2017-12-31 | $0.20 B | -741.5% |
| 2016-12-31 | $-32.49 M | -175.54% |
| 2015-12-31 | $42.99 M | 3.98% |
| 2014-12-31 | $41.35 M | -306.86% |
| 2013-12-31 | $-19.99 M | -140.92% |
| 2012-12-31 | $48.85 M | 348.19% |
| 2011-12-31 | $10.9 M | -46.44% |
| 2010-12-31 | $20.35 M | 194.8% |
| 2009-12-31 | $6.9 M | -55.11% |
| 2008-12-31 | $15.37 M | -73.38% |
| 2007-12-31 | $57.76 M | 150.28% |
| 2006-12-31 | $23.08 M | 26.77% |
| 2005-12-31 | $18.2 M | 22.82% |
| 2004-12-31 | $14.82 M | 3865.75% |
| 2003-12-31 | $0.37 M | -198.48% |
| 2002-12-31 | $-0.38 M | -1761.97% |
| 2001-12-31 | $0.02 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 81,961.38% | 🇺🇸 USA |
 Pfizer PFE | $89.28 B | 106,438.76% | 🇺🇸 USA |
 Eli Lilly LLY | $10.86 B | 12,862.61% | 🇺🇸 USA |
 Sanofi SNY | $82.20 B | 97,985.39% | 🇫🇷 France |
 Baxter BAX | $8.46 B | 10,004.05% | 🇺🇸 USA |
 MannKind Corp MNKD | -$0.25 B | -393.73% | 🇺🇸 USA |